Cedilla Therapeutics Funding: $83M Raised, Series B (2021)
Cedilla Therapeutics is based in Cambridge. It has raised $83M in total funding. Latest round: Series B.
Cedilla Therapeutics funding overview
Cedilla Therapeutics is based in Cambridge. Cedilla Therapeutics has raised $83M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2021. The round record for Cedilla Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include RA Capital Management, Janus Henderson Investors, Woodline Partners LP, Logos Capital, Third Rock Ventures. 5 distinct backers are named across the disclosed rounds.
Cedilla Therapeutics at a glance
Total raised
$83M
Latest round
Series B
Latest round date
October 2021
Headquarters
Cambridge
Notable investors
RA Capital Management, Janus Henderson Investors, Woodline Partners LP, Logos Capital, Third Rock Ventures
Frequently asked about Cedilla Therapeutics funding
How much has Cedilla Therapeutics raised?
Cedilla Therapeutics has raised $83M in total disclosed funding across the rounds on record.
Who has invested in Cedilla Therapeutics?
RA Capital Management, Janus Henderson Investors, Woodline Partners LP, Logos Capital, Third Rock Ventures are named among the investors backing Cedilla Therapeutics.
What was the latest Cedilla Therapeutics funding round?
The most recent disclosed round is a Series B, announced in October 2021.
Where is Cedilla Therapeutics based?
Cedilla Therapeutics is based in Cambridge.
When did Cedilla Therapeutics last raise?
The last disclosed Cedilla Therapeutics round closed in October 2021 at Series B.
Totals shown for Cedilla Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
